Baron Funds, an asset management company, released its “Baron Discovery Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.
Establishment Labs Holdings, Inc. (NASDAQ:NASDAQ:ESTA) Q2 2022 Earnings Conference Call August 08, 2022 04:30 PM ET Company Participants Juan Jose Chacon Quiros - Founder and CEO Rajbir.
Establishment Labs Completes Enrollment of One Hundred Patient Motiva Mia IRB Study apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Published: Dec 10, 2020
SANTA BARBARA, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it recently received Institutional Review Board (IRB) approval to initiate a patient series in Costa Rica to study its Motiva Mia
® system for minimally invasive augmentation, which includes the Motiva Ergonomix2 Diamond
® breast implant, and has completed the procedure in the first 21 patients in the study.
“Motiva Mia is truly disruptive to traditional breast aesthetics,” said Dr. Charles Randquist, an internationally recognized plastic surgeon. “Minimally invasive breast enhancement should define a more balanced approach in aesthetics: an augmentation that is considerably more subtle in its sizing and approach and is performed without general anesthesia through a very small incision with a quick recover